---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-023797"
form_type: "8-K"
ticker: "FZMD"
cik: "0000319016"
company_name: "Fuse Medical, Inc."
filed_at: "2023-08-15T23:59:59+00:00"
generated_at: "2026-06-11T09:44:29.351256+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Fuse Medical Q2 2023 net income $307,588 vs loss of $322,936 a year ago

## Summary
- Revenue rose 7% to $5.0M from $4.7M in Q2 2022.
- Gross profit grew 31% to $3.5M (69% margin) from $2.6M (57% margin).
- SG&A expense increased to $1.6M from $1.4M; commissions down slightly.
- EBITDA swung to $401,574 from a loss of $246,834 year-over-year.
- CEO cites growth from portfolio of Fuse branded/manufactured products and national distribution expansion.

## SEC filing metadata
- accession: 0001437749-23-023797
- form_type: 8-K
- ticker: FZMD
- cik: 0000319016
- company_name: Fuse Medical, Inc.
- filed_at: 2023-08-15T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/319016/000143774923023797/0001437749-23-023797-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/319016/000143774923023797/fzmd20230808c_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-023797
- JSON: https://secwatch.observer/filing/0001437749-23-023797.json
- Plain text: https://secwatch.observer/filing/0001437749-23-023797.txt

## Key facts
- Earnings Releases
  Fuse Medical, Inc. reported second quarter ending June 30, 2023 results: revenue $5.0 million, net income $307,588.
  - Period: second quarter ending June 30, 2023
  - Revenue: $5.0 million
  - Net income: $307,588
  - Result: reported results
  source text: quarter ended June 30, 2023 with the Securities and Exchange Commission (“SEC”). Second Quarter 2023 Financial Highlights ● Net revenues for the quarter ended June 30, 2023 were $5.0 million, compared to $4.7 million for the quarter ended June 30, 2022 which was an increase of approximately 7%. ● For the quarter ended June 30, 2023, gross profit was $3.5 million, or
  evidence_url: https://www.sec.gov/Archives/edgar/data/319016/000143774923023797/0001437749-23-023797-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.